CTC clusters induced by heparanase enhance breast cancer metastasis
Wei Rong-rui, Sun Dan-ni, Yang Hong, Yan Juan, Zhang Xiong, Zheng Xing-ling, Fu Xu-hong, Geng Mei-yu, Huang Xun, Ding Jian
Journal:ACTA PHARMACOLOGICA SINICA
IF:3.56
DOI:10.1038/aps.2017.189
PMID:29417941
Published:2018-02-08
research field:肿瘤学分子生物学细胞生物学
Abstract
Aggregated metastatic cancer cells, referred to as circulating tumor cell (CTC) clusters, are present in the blood of cancer patients and contribute to cancer metastasis. However, the origin of CTC clusters, especially intravascular aggregates, remains unknown. Here, we employ suspension culture methods to mimic CTC cluster formation in the circulation of breast cancer patients. CTC clusters generated using these methods exhibited an increased metastatic potential that was defined by the overexpression of heparanase (HPSE). Heparanase induced FAK- and ICAM-1-dependent cell adhesion, which promoted intravascular cell aggregation. Moreover, knockdown of heparanase or inhibition of its activity with JG6, a heparanase inhibitor, was sufficient to block the formation of cell clusters and suppress breast cancer metastasis. Our data reveal that heparanase-mediated cell adhesion is critical for metastasis mediated by intravascular CTC clusters. We also suggest that targeting the function of heparanase in cancer cell dissemination might limit metastatic progression.
本文使用的Yeasen产品


